Autoimmune Intervention Mastery Course Study

ConditionsMultiple Sclerosis Clinically Isolated Syndrome Fibromyalgia Post Acute Sequelae of COVID-19 Cancer in Remission With Persisting Fatigue

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-100

SponsorTerry L. Wahls

About this trial

The goal of this project is to critically evaluate the effectiveness of using an online program to improve diet and self-care in patients with multiple sclerosis (MS), clinically isolated syndrome (CIS), fibromyalgia, post acute sequela of covid, and cancer in remission with persisting fatigue.

Eligibility criteria

Qualifiers

self-reported multiple sclerosis

self-reported clinically isolated syndrome

Disqualifiers

None

Trial design

Treatments tested in this trial

Immediate Autoimmune Intervention Mastery Course (AIM)
Immediate Question and Answer sessions. (AIM Q and A sessions)
Delayed Autoimmune Intervention Mastery Course (delayed AIM course)
Delayed AIM Question and Answer sessions

Treatment groups

400 Participants

are divided into 2 treatment groups

Locations

Univeristy of Iowa52246, Iowa CityIowa, United States

Sponsors and collaborators

Terry L. Wahls

Lead sponsor

University of Iowa

Sponsor institution

Source ClinicalTrials.gov